P

ProQR Therapeutics NV

PRQR

1.81000
USD
-0.1
(-5.24%)
Market Open
Volume
14,884
EPS
0
Div Yield
0
P/E
-13
Market Cap
312,018,345
OverviewSignalsIdeasNews
Related Instruments
A
ARRY
-0.250
(-2.37%)
10.290 USD
A
ASND
2.930
(2.20%)
136.370 USD
F
FIXX
0
(0%)
0.000000 USD
F
FULC
-0.27000
(-2.91%)
9.01000 USD
R
RARE
-0.870
(-1.93%)
44.140 USD
S
SNDX
-0.750
(-3.30%)
21.990 USD
X
XNCR
-0.600
(-2.93%)
19.880 USD
News

Novo Nordisk Surges in Profit and Sales

5 months ago
Stocks news

Title: ProQR Therapeutics NV

Sector: Healthcare
Industry: Biotechnology
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.